Connect Learn Finance
Retmarker SA

Retmarker SA

To rate this company
Portugal
8 employees
Established in 2008

Company description


The company’s objective, to build a valuable global business on affordable healthcare for retinal diseases, relies on the Retmarker Technology and Operating Model. Retmarker, a patented and certified medical device, is a biomarker for Diabetic Retinopathy progression. Diabetic Retinopathy is the eye-sight complication of Diabetes (382 Million today and 592 Millions estimated in 2035) and the leading cause of blindness in the working population. To avoid blindness, all Diabetics should be screened at least once a year in order to provide early and timely treatment. Retmarker has been used with success in Diabetic Retinopathy Screening Programs since 2011. The aim of Retmarker is not to replace doctors and specialists, rather to provide efficient solutions that empower them to provide the best healthcare to those threatened by Diabetic Retinopathy. Retmarker allows the implementation of highly reliable and efficient Diabetic Retinopathy screening programs, at an extremely low cost.
Sector / Industry

{{industry.name}}
Products and Services
{{pas.productName}}
Show more

Commercial information


Main customers:

Public Health Systems

Certifications:

ISO 13485 (Medical Devices), ISO 9001, Patented Technology

Contact information


To see this content
Sign In to ConnectAmericas
Forgot your password?
Don't have an account? Register here
Enter the e-mail you used when you registered
for ConnectAmericas to create
a new password